Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "NFI"

1601 News Found

Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development
Biopharma | June 23, 2026

Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development

New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making


ZEISS and Envision Health Technologies team up to push VR-based glaucoma testing forward
Technology | June 23, 2026

ZEISS and Envision Health Technologies team up to push VR-based glaucoma testing forward

The move comes as demand rises for wider access to glaucoma screening and more flexible clinical workflows


Pfizer lung cancer drug misses key survival goal in Phase 3 trial
Clinical Trials | June 23, 2026

Pfizer lung cancer drug misses key survival goal in Phase 3 trial

The company said the safety profile remained consistent with earlier studies and was considered manageable


Pfizer CFO Dave Denton to exit
People | June 23, 2026

Pfizer CFO Dave Denton to exit

Pharma powerhouse names Cecile Guegan interim finance chief


India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
interviews | June 22, 2026

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India

Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors


Aurobindo Pharma USA secures FTC clearance for $250 million Lannett acquisition
Drug Approval | June 22, 2026

Aurobindo Pharma USA secures FTC clearance for $250 million Lannett acquisition

Through the transaction, Aurobindo USA will expand its product portfolio in this segment while gaining a U.S.-based manufacturing facility


Automated cell therapy manufacturing attracts US$1.1 Billion  across 34 funding rounds
Biopharma | June 20, 2026

Automated cell therapy manufacturing attracts US$1.1 Billion across 34 funding rounds

New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones


Quadria-backed HealthQuad closes Rs. 550 crore first close for fund 3
Healthcare | June 20, 2026

Quadria-backed HealthQuad closes Rs. 550 crore first close for fund 3

Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge


Brinton Pharma appoints Sathya Narayanan as CEO – India and JPAC
People | June 18, 2026

Brinton Pharma appoints Sathya Narayanan as CEO – India and JPAC

Industry veteran with over two decades of experience to lead expansion across India, South Asia, Southeast Asia, and other high-growth healthcare markets


More men under 50 seeking help for low testosterone: Apollo Spectra Hospital
Hospitals | June 18, 2026

More men under 50 seeking help for low testosterone: Apollo Spectra Hospital

Hospital data reveals a sharp rise in consultations related to hormonal health, erectile dysfunction and male fertility, highlighting growing awareness among younger men.